DWF Group: A transformational year
A transformed model: The impressive turnaround in performance reported in FY21A results reflects strong progress made in restructuring DWF Group plc (LON:DWF) to simplify its operating model, and to refocus
A transformed model: The impressive turnaround in performance reported in FY21A results reflects strong progress made in restructuring DWF Group plc (LON:DWF) to simplify its operating model, and to refocus
Consumer demand for Escape Hunt plc (LON:ESC) experiential leisure sites has rebounded strongly since reopening. At the same time, the company continues to gain scale with acquisitions outperforming and site
Inchcape plc (LON:INCH) has delivered a strong set of H1 results, which are 13% ahead of our forecasts at the adjusted PBT level. The Group is seeing strong growth across
Vertu Motors plc (LON:VTU) has released an unscheduled trading update, delivering another earnings upgrade to 2022E, this time in excess of 30%. This is driven by the strength of the
City of London Investment Group plc (LON:CLIG) is the topic of conversation when Dr Brian Moretta, Analyst at Hardman & Co joins DirectorsTalk following the End of year trading statement
Lookers plc (LON:LOOK), one of the leading UK motor retail and aftersales service groups, has provided a trading update covering the six month period ended 30 June 2021 and an
Vertu Motors plc (LON:VTU) has announced that, as a consequence of the continuing strong trading performance, the Group is providing an update on current trading and an upgrade to the
OnTheMarket plc (LON:OTMP), the majority agent-owned company which operates the OnTheMarket.com property portal, has provided the following statement ahead of its Annual General Meeting to be held today. Christopher Bell,
Oncimmune Holdings plc (LON:ONC) announced a new contract with the Dana-Farber Cancer Institute (Harvard Medical School affiliate based in Boston, US) whereby the latter will utilise Oncimmune’s proprietary SeroTagTM ‘biomarker discover
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced it has signed an autoantibody profiling contract with Dana-Farber Cancer Institute in Boston, Massachusetts. Dana-Farber, a clinical affiliate and